That’s a fair point WAG but I’m more interested in Taysha’s share price getting smacked down ~25% on questionable trial results and NEU’s share price getting smacked down a similar percentage on fantastic trial results in PHS. Apples and oranges I know but it’s a funny old market….
While I’m here, the FDA has a new program called Operation Warp Speed for rare disease development I might write to Jon about it.
https://www.fiercebiotech.com/research/fda-selects-denali-neurogene-larimar-and-grace-sciences-rare-disease-therapy-pilot
That’s a fair point WAG but I’m more interested in Taysha’s...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.93 |
Change
-0.240(1.19%) |
Mkt cap ! $2.576B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.45 | $19.87 | $1.080M | 53.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 195 | $19.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.92 | 203 | 2 |
View Market Depth
| Last trade - 12.45pm 29/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |